# Blood Volume Assessment in COVID-19 and Bacterial Sepsis

> **NCT04517695** · — · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 39 (actual)

## Conditions studied

- Covid19
- Acute Respiratory Distress Syndrome
- Bacterial Sepsis
- Bacterial Infections

## Interventions

- **DEVICE:** BVA-100
- **DEVICE:** Transpulmonary Thermodilution (TPTD)
- **DEVICE:** Sublingual Microcirculation

## Key facts

- **NCT ID:** NCT04517695
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2023-04-09
- **Final completion:** 2023-04-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04517695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04517695, "Blood Volume Assessment in COVID-19 and Bacterial Sepsis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04517695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*